Strategic CDMO Formex operates as a contract development and manufacturing organization (CDMO) focused on oral and topical dosage forms with specialty in bioavailability enhancement. This presents an opportunity to position services for clients seeking advanced formulation capabilities, scale-up, and cGMP manufacturing for small-molecule APIs.

Tech-Enabled Advantage Leveraging technologies such as spray-dry dispersion and hot-melt extrusion, along with analytical method development and stability testing, Formex can target pharma companies needing innovative formulation platforms to improve bioavailability and pipeline viability.

San Diego Footprint Based in San Diego with a mid-size team, Formex appears poised to partner with regional biotech and pharma firms seeking local development and manufacturing support, reducing logistics risk for clinical and early-commercial programs.

Growth & Leadership Past leadership additions and advisory roles indicate a focus on strategic growth, quality assurance, and business development. This suggests receptivity to partnerships, joint ventures, and sponsored research to accelerate product timelines.

Market Readiness With revenue in the ten-million-dollar range and a suite of services from pre-formulation to cGMP manufacturing, Formex is positioned to upsell comprehensive development packages to pharmaceutical clients seeking integrated CDMO solutions for small-molecule APIs.